The American College of Physicians released a new clinical practice guideline on diagnosing and treating stable chronic obstructive pulmonary disease (COPD), a slowly progressive lung disease involving the airways and lung tissue, resulting in a gradual loss of lung function, typically as a result of smoking. COPD affects more than 5 percent of the adult population in the United States and is the fourth leading cause of death and twelfth leading cause of illness. The symptoms of COPD range from chronic cough and wheezing to more severe symptoms such as shortness of breath and significant activity limitation. The term COPD includes both emphysema and chronic bronchitis. Physicians often use the broader term COPD, since affected patients frequently have components of both conditions.
From http://hhcbooks.com/respiratory_diseases/contemporary_diagnosis_and_management_of_copd – Leading Pulmonology experts Antonio Anzueto and Fernando Martinez talk about what’s new in the field of COPD
The revolutionary copd-6 range of COPD screeners from Vitalograph is designed to identify undiagnosed COPD, quickly, simply and accurately.
Effective management of COPD depends on objective early detection and correct diagnosis. The high performing, low cost, copd-6 range supports these objectives by screening out those who do not have COPD, allowing spirometry resources to be focussed on those most at risk. Possible COPD patients are categorised for severity according to GOLD guidelines built into the copd-6.
In addition to the standard copd-6, Vitalograph have recently introduced the copd-6 usb which links to a PC to produce electronic and hard copy colour reports. The copd-6 usb records FEV1, FEV6 and the FEV1/FEV6 ratio, plus predicted values and patient information including demographic data. Reports feature the GOLD classification indicator for COPD and an interpretation which includes the subjects lung age. Each report is date and time stamped and can be customised.
The American College of Physicians has released an updated clinical practice guideline for the diagnosis and treatment of chronic obstructive pulmonary disease (COPD). COPD is a collection of slowly progressing lung diseases more commonly found in smokers. Over 5% of adults in the US have COPD and it is the fourth primary cause of death and twelfth leading cause of illness. A patient suffering from the disease will typically have a chronic cough, wheezing, and some patients also have a shortness of breath and and activity limitation.
Story is produced and provided by Empowered Medical Media, LLC
Visit http://www.EmpoweredDoctor.com to see the full story
And if you are looking for a doctor check out our local doctor directory at:
http://www.empowereddoctor.com/directory_doctor.php
The American College of Physicians released a new clinical practice guideline on diagnosing and treating stable chronic obstructive pulmonary disease (COPD), a slowly progressive lung disease involving the airways and lung tissue, resulting in a gradual loss of lung function, typically as a result of smoking. COPD affects more than 5 percent of the adult population in the United States and is the fourth leading cause of death and twelfth leading cause of illness. The symptoms of COPD range from chronic cough and wheezing to more severe symptoms such as shortness of breath and significant activity limitation. The term COPD includes both emphysema and chronic bronchitis. Physicians often use the broader term COPD, since affected patients frequently have components of both conditions.
From http://hhcbooks.com/respiratory_diseases/contemporary_diagnosis_and_management_of_copd – Leading Pulmonology experts Antonio Anzueto and Fernando Martinez talk about what’s new in the field of COPD
The revolutionary copd-6 range of COPD screeners from Vitalograph is designed to identify undiagnosed COPD, quickly, simply and accurately. 
http://www.empowereddoctor.com/story_1331.html